A detailed history of Enterprise Trust & Investment CO transactions in Catalent, Inc. stock. As of the latest transaction made, Enterprise Trust & Investment CO holds 21 shares of CTLT stock, worth $1,333. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21
Holding current value
$1,333
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

BUY
$87.2 - $114.05 $1,831 - $2,395
21 New
21 $2,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Enterprise Trust & Investment CO Portfolio

Follow Enterprise Trust & Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Trust & Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Trust & Investment CO with notifications on news.